| 12410160 |
KHK inhibitors |
James L. Bachman, Christopher T. Clark, Petr Jansa, Joshua A. Kaplan, Zachary A. Kasun +4 more |
2025-09-09 |
|
| 12404289 |
1′-cyano nucleoside analogs and uses thereof |
Byoung-Kwon Chun, Michael O'Neil Hanrahan Clarke, Petr Jansa, Rao V. Kalla, Dmitry Koltun +4 more |
2025-09-02 |
|
| 12240862 |
Inhibitors of peptidylarginine deiminases |
Eda Canales, Laurent P. Debien, Petr Jansa, Rick Lee, Jennifer A. Loyer-Drew +10 more |
2025-03-04 |
|
| 12180217 |
Compounds and methods for treatment of viral infections |
Mark J. Bartlett, Yifan Deng, Jennifer L. Cosman Ellis, Rao V. Kalla, Richard L. Mackman +2 more |
2024-12-31 |
$374,549,000 |
| 12110305 |
Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical use |
Byoung-Kwon Chun, Michael O'Neil Hanrahan Clarke, Petr Jansa, Devan Naduthambi, Neil H. Squires |
2024-10-08 |
$323,137,000 |
| 12030903 |
Antiviral compounds |
Gregory Chin, Michael O' Neil Hanrahan Clarke, Bindu Goyal, Petr Jansa, Richard L. Mackman +2 more |
2024-07-09 |
$175,383,000 |
| 11939347 |
1′-cyano nucleoside analogs and uses thereof |
Byoung-Kwon Chun, Michael O'Neil Hanrahan Clarke, Petr Jansa, Rao V. Kalla, Dmitry Koltun +4 more |
2024-03-26 |
$240,166,000 |
| 11878965 |
Inhibitors of peptidylarginine deiminases |
Zhenhong R. Cai, Eda Canales, Laurent P. Debien, Timothy R. Hansen, Richard Huang +13 more |
2024-01-23 |
$552,258,000 |
| 11851438 |
1′-cyano nucleoside analogs and methods for treatment of viral infections |
Mark J. Bartlett, Yifan Deng, Jennifer L. Cosman Ellis, Rao V. Kalla, Richard L. Mackman +2 more |
2023-12-26 |
$246,645,000 |
| 11845755 |
Compounds and methods for treatment of viral infections |
Mark J. Bartlett, Yifan Deng, Jennifer L. Cosman Ellis, Rao V. Kalla, Richard L. Mackman +2 more |
2023-12-19 |
$116,955,000 |
| 11780844 |
Compounds and methods for treatment of viral infections |
Mark J. Bartlett, Yifan Deng, Jennifer L. Cosman Ellis, Rao V. Kalla, Richard L. Mackman +2 more |
2023-10-10 |
$551,120,000 |
| 11718637 |
Prodrugs of 4′-C-substituted-2-halo-2′- deoxyadenosine nucleosides and methods of making and using the same |
Byoung-Kwon Chun, Michael O'Neil Hanrahan Clarke, Petr Jansa, Richard L. Mackman, Devan Naduthambi +1 more |
2023-08-08 |
$593,843,000 |
| 10836744 |
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity |
Adam D. Hughes, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more |
2020-11-17 |
|
| 10590107 |
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity |
Adam D. Hughes, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more |
2020-03-17 |
|
| 10358433 |
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity |
Adam D. Hughes, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more |
2019-07-23 |
|
| 10138220 |
Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity |
Adam D. Hughes, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more |
2018-11-27 |
|
| 9975875 |
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity |
Adam D. Hughes, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more |
2018-05-22 |
|
| 9771350 |
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity |
Adam D. Hughes, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more |
2017-09-26 |
|
| 9682957 |
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity |
Adam D. Hughes, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more |
2017-06-20 |
|
| 9572802 |
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity |
Adam D. Hughes, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more |
2017-02-21 |
|
| 9394275 |
Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity |
Adam D. Hughes, John R. Jacobsen |
2016-07-19 |
|
| 8138345 |
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity |
Adam D. Hughes, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more |
2012-03-20 |
$17,721,000 |